3 documents found, page 1 of 1

Sort by Issue Date

Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan i...

Gonçalves, J; Santos, CD; Fresco, P; Fernandez-Llimos, F

[No abstract available]


Reply to: RAAS inhibitors in COVID-19: Not all are created equal!

Gonçalves, J; Santos, CD; Fresco, P; Fernandez-Llimos, F

[No abstract available]


Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVI...

Goncalves, J; Santos, CD; Fresco, P; Fernandez-Llimos, F

SARS-CoV-2 infection and its clinical manifestations (COVID-19) quickly evolved to a pandemic and a global public health emergency. The limited effectivity of available treatments aimed at reducing virus replication and the lessons learned from other coronavirus infections (SARS-CoV-1 or NL63) that share the internalization process of SARS-CoV-2, led us to revisit the COVID-19 pathogenesis and potential treatme...


3 Results

Queried text

Refine Results

Author






Date



Document Type


Access rights


Resource